共 139 条
[1]
Calugi C(2011)Novel small molecules for the treatment of infections caused by Candida albicans: a patent review 2 Expert Opin Ther Pat 21 381-97
[2]
Trabocchi A(2010)Fungal infections in oncology patients: update on epidemiology, prevention, and treatment Curr Opin Oncol 22 138-42
[3]
Guarna A(2008)Bloodstream infections: evolution and trends in the microbiology workload, incidence, and etiology, 1985-2006 Medicine (Baltimore) 87 234-49
[4]
Marr KA(2010)Antifungal drug resistance of oral fungi Odontology 98 15-25
[5]
Rodriguez-Creixems M(1955)A new antifungal antibiotic, amphotericin B Antibiot Annu 3 566-73
[6]
Alcala L(2005)Molecular modelling of membrane activity of amphotericin B, a polyene macrolide antifungal antibiotic Acta Biochim Pol 52 655-8
[7]
Munoz P(2011)Amphotericin B mediates killing in Cryptococcus neoformans through the induction of a strong oxidative burst Microbes Infect 13 457-67
[8]
Cercenado E(2002)Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance J Hosp Infect 50 243-60
[9]
Vicente T(1997)Resistance to fluconazole and cross-resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol delta5,6-desaturation FEBS Lett 400 80-2
[10]
Bouza E(2004)Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans J Antimicrob Chemother 54 376-85